Welcome to myAZmed

This is a non-promotional website developed and funded by AstraZeneca and it is intended for UK patients, or their carers, who have been prescribed an AstraZeneca medicine. This website is not intended to replace the discussions between you and your healthcare professional and it is not a substitute for the Patient Information Leaflet which is provided with your medicine.

 

Please select the option below which applies to you.

LEARN ABOUT AN ASTRAZENECA MEDICINE YOU HAVE BEEN PRESCRIBED

If you are a UK patient, or their carer, prescribed an AstraZeneca medicine, please enter myAZmed using the button below.

DISCOVER DISEASE EDUCATION AND SUPPORT FROM ASTRAZENECA

Discover disease education and resources for some of the conditions relevant to AstraZeneca’s work, using the button below.

If you are a UK healthcare professional looking for further information, you can visit our AZ UK Medical Information website.

 

If none of the above options apply, this website is not appropriate for you. To learn more about AstraZeneca as a company you 
can visit astrazeneca.co.uk.

I am a member of the UK public looking for disease education

This website is intended for UK patients, or their carers, who have been prescribed an AstraZeneca medicine. If this is not you, please go to https://www.astrazeneca.co.uk/

logo
  • About myAZmed

Welcome to myAZmed

Here you will find information and resources related to your AstraZeneca (AZ) medicine.

Which best describes you?

  • A patient or
    carer of a patient

    who has been prescribed an AZ medicine.

  • A healthcare professional

    who supports patients who use AZ medicine.

  • None of these.

    myAZmed has been created for people who use AZ medicines. If that’s not you but you’d like to learn more about AstraZeneca, please click here.

Approval ID: GB-69418 Date of preparation: September 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.

Find your medicine

16 84
16

Your progress

Which type of AZ medicine are you here to learn more about today? 

  • Inhaler

    An inhaler device helps medicine go straight into your lungs when you breathe in.

  • injection

    Injection

    An injection allows medicine to be given using a needle and a syringe, or a pen device.

  • Tablet

    Tablets, pills and capsules allow medicine to be swallowed and absorbed by your digestive tract.

  • Sachet

    Sachets contain a powder that can be mixed with water for oral suspension, which allows the medicine to be taken as a drink to pass through your digestive tract

This website is not a substitute for the Patient Information Leaflet (PIL) that is provided with your Astrazeneca medicine. Please read the PIL before you start treatment.

Approval ID: GB-69418 Date of preparation: September 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.

Find your medicine

32 68
32

Your progress

Which type of inhaler have you been prescribed?

  • Symbicort®

    (budesonide/formoterol fumarate dihydrate)

  • Trixeo Aerosphere®

    (formoterol fumarate dihydrate/ glycopyrronium/ budesonide)

  • I can’t see my medicine here

Approval ID: GB-69418 Date of preparation: September 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.

Find your medicine

32 68
32

Your progress

Which type of injection have you been prescribed?

  • Fasenra®

    (benralizumab)

  • Tezspire®▼

    (tezepelumab)

  • I can’t see my medicine here

Approval ID: GB-69418 Date of preparation: September 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.

 

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get as advised above.

Find your medicine

32 68
32

Your progress

Which type of tablet have you been prescribed?

  • Forxiga®

    (dapagliflozin)

  • Lynparza®

    (olaparib)

  • Tagrisso®

    (osimertinib)

  • Truqap®▼

    (capivasertib)

  • I can’t see my medicine here

Approval ID: GB-69418 Date of preparation: September 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard/. By reporting side effects you can help provide more information on the safety of medicines.

 

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get as advised above.

Find your medicine

50 50
50

Your progress

Click on the medicine that matches yours

  • Symbicort Turbohaler 100/6 and its box. Its strength, 100/6, is written on the front.

    Symbicort® Turbohaler® 100/6

    (budesonide/formoterol fumarate dihydrate)

  • Symbicort Turbohaler 200/6 and its box. Its strength, 200/6, is written on the front.

    Symbicort® Turbohaler® 200/6

    (budesonide/formoterol fumarate dihydrate)

  • Symbicort Turbohaler 400/12 and its box. Its strength, 400/12, is written on the front.

    Symbicort® Turbohaler® 400/12

    (budesonide/formoterol fumarate dihydrate)

  • Symbicort pressurised metered dose inhaler 100/3 and its box. Its strength, 100/3, is written on the front.

    Symbicort® pMDI 100/3

    (budesonide/formoterol fumarate dihydrate)

  • Symbicort pressurised metered dose inhaler 200/6 and its box. Its strength, 200/6, is written on the front.

    Symbicort® pMDI 200/6

    (budesonide/formoterol fumarate dihydrate)

  • I can’t see my medicine here

Approval ID: GB-72511 Date of preparation: December 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard/. By reporting side effects you can help provide more information on the safety of medicines.

Find your medicine

50 50
50

Your progress

Click on the medicine that matches yours

  • Trixeo Aeropshere and its box. Each inhaler contains 120 inhalations.

    Trixeo Aerosphere®

    (formoterol fumarate dihydrate/ glycopyrronium/ budesonide)

  • I can’t see my medicine here

Approval ID: GB-72341 Date of Preparation: November 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.

Find your medicine

50 50
50

Your progress

Click on the medicine that matches yours

  • Fasenra Pen and its box. Each pen contains a single 30mg dose.

    Fasenra® 30mg solution for injection in pre-filled pen

    (benralizumab)

  • Fasenra pre-filled syringe and its box. Each syringe contains a single 30mg dose.

    Fasenra® 30mg solution for injection in pre-filled syringe

    (benralizumab)

  • I can’t see my medicine here

Find your medicine

65 35
65

Your progress

Who is the medicine for?

  • Four face icons of a young man and woman and old man and woman

    Adult

    (18 years +)

  • Faces of young boy and girl

    Child

    (10 to 17 years)

GO BACK

Approval ID: GB-57318 Date of preparation: July 2024

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of medicines.

I can't find my AZ medicine

If you can't see your AZ medicine on myAZmed, this may be because it hasn't been added yet. 

 

Thank you for your patience while you wait for your medicine to be featured. 

 

In the meantime, if you have questions about an AZ medicine that you have been prescribed, please contact your doctor, nurse or pharmacist. 

 

You can also call AstraZeneca's UK-based Medical Information Team on: 0800 783 0033. Lines are open Monday to Friday, from 9am to 5pm.

Find another med
WKND LOGO

Approval ID: GB-69418 Date of preparation: September 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.

I can't find my AZ medicine

If you can't see your AZ medicine on myAZmed, this may be because it hasn't been added yet. 

 

Thank you for your patience while you wait for your medicine to be featured. 

 

In the meantime, if you have questions about an AZ medicine that you have been prescribed, please contact your doctor, nurse or pharmacist. 

 

You can also call AstraZeneca's UK-based Medical Information Team on: 0800 783 0033. Lines are open Monday to Friday, from 9am to 5pm.

Find another med
WKND LOGO

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.

Find your medicine

50 50
50

Your progress

Click on the medicine that matches yours

  • Fasenra Pen and its box. Each pen contains a single 30mg dose.

    Bydureon® 2 mg prolonged-release suspension for injection in pre-filled pen

    (exenatide)

     

  • I can’t see my medicine here

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of medicines.

 

Side effects can also be reported to AstraZeneca in the following ways:

Online https://contactazmedical.astrazeneca.com

Email Medical.InformationUK@astrazeneca.com

Telephone 0800 783 0033

Find your medicine

50 50
50

Your progress

Click on the medicine that matches yours

  • Fasenra Pen and its box. Each pen contains a single 30mg dose.

    Forxiga® film-coated tablets

    (dapagliflozin)

  • I can’t see my medicine here

Approval ID: GB-57318 Date of preparation: July 2024

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of medicines.

Find your medicine

50 50
50

Your progress

Click on the medicine that matches yours

  • Lynparza® film-coated tablets

    (olaparib)

  • I can’t see my medicine here

Approval ID: GB-64896 Date of preparation: June 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard/. By reporting side effects you can help provide more information on the safety of medicines.

Find your medicine

32 68
32

Your progress

Which type of oral suspension have you been prescribed?

  • Lokelma®

    (sodium zirconium cyclosilicate)

  • I can’t see my medicine here

Approval ID: GB-69418 Date of preparation: September 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.

Find your medicine

50 50
50

Your progress

Click on the medicine that matches yours

  • Lokelma®

    (sodium zirconium cyclosilicate)

    Powder for oral suspension

  • I can’t see my medicine here

Approval ID: GB-73271 Date of preparation: January 2026

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of medicines.

Find your medicine

50 50
50

Your progress

Click on the medicine that matches yours

  • Truqap▼ film coated tablets

    (capivasertib)

  • I can’t see my medicine here

Approval ID: GB-67381 Date of preparation: September 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard/. By reporting side effects you can help provide more information on the safety of medicines.

 

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get as advised above.

You are now leaving myAZmed
 
This link will take you to a different AstraZeneca website.

Please confirm that you are happy to continue, or close this window to remain on myAZmed.co.uk.

CONTINUE

You are now leaving myAZmed
 
This link will take you to a different AstraZeneca website.

Please confirm that you are happy to continue, or close this window to remain on myAZmed.co.uk.

CONTINUE

You are now leaving myAZmed
 
myAZmed is intended for UK patients, or their carers, who have been prescribed an AstraZeneca medicine

If you are a UK healthcare professional you will be taken to AZ UK Medical Information

Please confirm that you are happy to continue
CONTINUE

You are now leaving myAZmed
 
This link will take you to a different AstraZeneca website.

Please confirm that you are happy to continue, or close this window to remain on myAZmed.co.uk.

CONTINUE
FOOTER LOGO
  • Cookie policy
  • Terms of use
  • Privacy policy
  • Contact us

© Copyright 2022. AstraZeneca Ltd

Approval ID: GB-53223 Date of preparation: May 2024